Sie suchten nach: postmenopausal (Englisch - Maltesisch)

postmenopausal osteoporosis
osteoporożi wara l-menopawża

postmenopausal women.
f’ nisa wara l- menopawża

in postmenopausal women,
f’nisa wara l-menopawsa,

adult (postmenopausal women):
adulti (nisa li jkunu diġà għaddew mill-menopawsa):

treatment of postmenopausal osteoporosis:
kura ta’ osteoporożi menopawsali:

effects on the postmenopausal endometrium
effetti fuq l-endometriju fi żmien ta’ wara l-menopawża

fracture incidence in postmenopausal women:
każijiet ta’ ksur fin-nisa wara l-menopawża

treatment of osteoporosis in postmenopausal women
kura ta’ osteoporożi f’nisa wara l-menopawsa

toremifene is recommended for postmenopausal patients.
toremifene huwa rrakkomandat għall-pazjenti li għaddew mill-menopawsa.

evista is only for use in postmenopausal women.
evista għandha tintuża biss fin-nisa wara l-menopawsa.

this medicine is for use only by postmenopausal women.
din il-mediċina hija għall-użu biss minn nisa li għaddew mill-menopawża.

fracture incidence in postmenopausal women over 5 years
inċidenza ta ’ ksur fuq perjodu ta ’ 5 snin f’ nisa li diġà għaddew mill- menopawsa

adrovance is only intended for use in postmenopausal women.
adrovance huwa maħsub biex jintuża f'nisa wara l-menopawsa.

the medicinal product has only been studied in postmenopausal women.
dan il-prodott mediċinali ġie studjat biss f’nisa li qabżu l-menopawsa.

evista does not treat postmenopausal symptoms, such as hot flushes.
evista ma tneħħilekx is-sintomi li jitfaċċaw wara l-menopawsa, bħall-fwawar.

about 12% of women in the clinical trials were postmenopausal.
madwar 12% tan- nisa fil- provi klini i kienu nisa li di à kellhom il- menopawsa.

open-label extension study in the treatment of postmenopausal osteoporosis
studju ta’ estensjoni open-label fil-kura ta’ osteoporożi ta’ wara l-menopawża

pregnancy and lactation: fablyn is only for use in postmenopausal women.
tqala u treddigħ: fablyn huwa indikat biss għall-użu min-nisa li diġà għaddew mill-menopawsa.

in clinical trials, evista did not stimulate the postmenopausal uterine endometrium.
fi provi kliniċi, evista ma stimulatx l-endometriju ta’ l-utru fil-perijodu ta’ wara l-menopawsa.

vertebral fractures are the most common type of osteoporotic fracture in postmenopausal women.
ksur vertebrali huwa l-aktar tip komuni ta’ ksur ikkawżat mill-osteoporożi f’nisa li diġà għaddew mill-menopawsa.